BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9839127)

  • 21. International Diabetes Federation meeting, 1997. Issues in the treatment of type 2 diabetes; sulfonylureas, metformin, and troglitazone.
    Bloomgarden ZT
    Diabetes Care; 1998 Jun; 21(6):1024-6. PubMed ID: 9614626
    [No Abstract]   [Full Text] [Related]  

  • 22. Deterioration of glycemic control after long-term treatment with troglitazone in nonobese type 2 diabetic patients.
    Murase Y; Wakasugi T; Yagi K; Mabuchi H
    Diabetes Care; 2000 Jan; 23(1):131-2. PubMed ID: 10857989
    [No Abstract]   [Full Text] [Related]  

  • 23. Troglitazone: a new class of oral antihyperglycemic for the treatment of type II diabetes.
    Teter ML
    Nurse Pract; 1997 Jul; 22(7):119-21. PubMed ID: 9253019
    [No Abstract]   [Full Text] [Related]  

  • 24. [Troglitazone, an insulin action enhancer--a drug of precision to treat adult-onset diabetes].
    Westerbacka J; Yki-Järvinen H
    Duodecim; 1997; 113(19):1847-8. PubMed ID: 10892078
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of psoriasis with troglitazone therapy.
    Pershadsingh HA; Sproul JA; Benjamin E; Finnegan J; Amin NM
    Arch Dermatol; 1998 Oct; 134(10):1304-5. PubMed ID: 9801703
    [No Abstract]   [Full Text] [Related]  

  • 26. Another potential use of troglitazone in noninsulin-dependent diabetes mellitus.
    Minamikawa J; Yamauchi M; Inoue D; Koshiyama H
    J Clin Endocrinol Metab; 1998 Mar; 83(3):1041-2. PubMed ID: 9506772
    [No Abstract]   [Full Text] [Related]  

  • 27. Troglitazone decreases collagen accumulation in prediabetic stage of a type II diabetic rat model.
    Yao L; Mizushige K; Noma T; Murakami K; Ohmori K; Matsuo H
    Heart; 2000 Aug; 84(2):209. PubMed ID: 10908265
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of troglitazone on coronary stent implantation using small stents in patients with type 2 diabetes mellitus.
    Takagi T; Yamamuro A; Tamita K; Yamabe K; Katayama M; Morioka S; Akasaka T; Yoshida K
    Am J Cardiol; 2002 Feb; 89(3):318-22. PubMed ID: 11809434
    [No Abstract]   [Full Text] [Related]  

  • 29. New directions in treating insulin resistance.
    Reusch JE
    Hosp Pract (1995); 1995 Sep; 30(9):9-10. PubMed ID: 7559840
    [No Abstract]   [Full Text] [Related]  

  • 30. Troglitazone for non-insulin-dependent diabetes mellitus.
    Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diabetic dyslipoproteinemia: physiopathological bases and treatment prospects].
    Demant T
    Fortschr Med Orig; 2001; 119(1):37-40. PubMed ID: 11935656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel antidiabetic drug, troglitazone--reason for hope and concern.
    Imura H
    N Engl J Med; 1998 Mar; 338(13):908-9. PubMed ID: 9516229
    [No Abstract]   [Full Text] [Related]  

  • 33. The glitazones: proceed with caution.
    Krische D
    West J Med; 2000 Jul; 173(1):54-7. PubMed ID: 10903299
    [No Abstract]   [Full Text] [Related]  

  • 34. Troglitazone decreases serum uric acid concentrations in type II diabetic patients and non-diabetics.
    Iwatani M; Wasada T; Katsumori K; Watanabe-Takahashi C; Kamatani N; Iwamoto Y
    Diabetologia; 2000 Jun; 43(6):814-5. PubMed ID: 10907128
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of troglitazone on insulin action and cardiovascular risk factors in patients with non-insulin-dependent diabetes.
    Sironi AM; Vichi S; Gastaldelli A; Pecori N; Anichini R; Foot E; Seghieri G; Ferrannini E
    Clin Pharmacol Ther; 1997 Aug; 62(2):194-202. PubMed ID: 9284856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving management of type 2 diabetes mellitus: 5. Thiazolidinediones.
    Samraj GP; Kuritzky L; Quillen DM
    Hosp Pract (1995); 2000 Jan; 35(1):123-4, 129-32. PubMed ID: 10645993
    [No Abstract]   [Full Text] [Related]  

  • 37. Pulmonary edema associated with troglitazone therapy.
    Hirsch IB; Kelly J; Cooper S
    Arch Intern Med; 1999 Aug 9-23; 159(15):1811. PubMed ID: 10448787
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study.
    Stakos DA; Schuster DP; Sparks EA; Wooley CF; Osei K; Boudoulas H
    J Cardiol; 2003 Apr; 41(4):183-90. PubMed ID: 12728539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of troglitazone on insulin sensitivity.
    Henry RR
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S148-50. PubMed ID: 8894499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A treatment for Mr WP: thiazolidinediones after troglitazone.
    Montague CT
    Diabet Med; 2002; 19 Suppl 1():7-9. PubMed ID: 11871423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.